Characteristic | Overall | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 |
---|---|---|---|---|---|---|---|
Eligible surveys (N) | 85 | 3 | 4 | 2 | 25 | 6 | 45 |
Percentage using a cluster sampling design | 85.9 | 100.0 | 75.0 | 100.0 | 80.0 | 100.0 | 86.7 |
Sample size | 640 (265 to 1075) | 534 (510 to 630) | 668 (641 to 833) | 683 (501 to 865) | 636 (265 to 886) | 915 (509 to 1018) | 630 (420 to 1075) |
GAM prevalence (weight-for-height + oedema), % | 14.8 (5.6 to 36.6) | 12.6 (8.7 to 16.7) | 11.4 (8.4 to 21.6) | 11.8 (8.6 to 15.1) | 15.6 (7.1 to 27.2) | 21.4 (17.5 to 36.6) | 14.4 (5.6 to 21) |
SAM prevalence (weight-for-height + oedema), % | 3.2 (0.6 to 9.2) | 3.0 (2.8 to 4.1) | 1.9 (0.6 to 4.7) | 3.0 (2.2 to 3.9) | 3.9 (0.6 to 6.4) | 7.3 (4.4 to 9.2) | 3.0 (1.3 to 6.4) |
GAM prevalence (MUAC + oedema), % | 7.6 (0.8 to 26.7) | 8.3 (3.7 to 12.0) | 3.1 (1.4 to 6.8) | 5.7 (2.0 to 9.3) | 7.4 (0.8 to 20.5) | 18.0 (9.1 to 22.6) | 7.6 (1.3 to 26.7) |
SAM prevalence (MUAC + oedema), % | 1.1 (0.1 to 6.8) | 2.2 (0.3 to 2.6) | 0.6 (0.3 to 1.1) | 1.6 (0.6 to 2.6) | 1.3 (0.2 to 4.4) | 3.0 (0.6 to 6.8) | 1.1 (0.1 to 3.6) |
Percentage of flagged observations | 0.7 (0.0 to 4.8) | 0.2 (0.2 to 1.0) | 0.0(0.0 to 2.4) | 0.8 (0.2 to 1.4) | 0.7 (0.0 to 3) | 1.4 (1.1 to 2.6) | 0.7 (0.0 to 4.8) |